The main market opportunities include training on modern technologies for computer system validation, compliance with evolving FDA regulations, and risk-based approaches to validation using CSA and ...

On January 6, 2026, the U.S. Food and Drug Administration (“FDA”) published revised final guidance documents on Clinical Decision Support ...

Korrapati's implementation work is complemented by industry engagement, including presenting on CSA implementation and roadblocks at professional venues ...

Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "IQ, OQ, PQ in the Verification and Validation Process (Jan 28, 2026)" training has been added to ResearchAndMarkets.com's offering. This course will ...

AI is reshaping the life sciences industry in ways that are no longer hypothetical. The question is no longer whether to ...

Jan 6 (Reuters) - The U.S. Food and Drug Administration said on Tuesday that it will limit regulation of wearable devices and software designed to support healthy lifestyles, issuing new guidance to ...

(MENAFN- GlobeNewsWire - Nasdaq) Market opportunities lie in enhancing risk-based V&V planning, focusing on DQ, IQ, OQ, and PQs to address cGMP deficiencies and regulatory expectations. By aligning ...

PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...

The FDA has issued a Class I recall for GE Healthcare’s Carestation anesthesia systems. Certain Carestation 600 and 700 series anesthesia systems with specific power management boards may shut down ...

Tony Scott had already boarded his flight from Seattle to Dallas back in July when his problems started. It was about 8 p.m. on a Sunday night when the flight crew asked the passengers to get off the ...

BOSTON, MA, UNITED STATES, January 6, 2026 / EINPresswire.com / — UltraSight™, a leader in AI-guided cardiac imaging workflows, today announced FDA clearance to expand its Echo Stewardship Platform to ...